Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results. Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones Discounted offers are only available to new members. Stock Advisor list price is 199 per year. AstraZeneca plc is a company that operates in the healthcare, pharmaceutical and biotechnology industry. The website here global company headquarters were moved to Cambridge in the United Kingdom in 2016 while some of the research and development centres are located in Cambridge, Gaithersburg (United States) and Gothenburg in Sweden. The company has established a network of production facilities in more than a dozen countries with multiple research sites and sales activities in many countries. AstraZeneca plc was formed after the merger in 1999 between Astra AB of Sweden and Zeneca plc from the United Kingdom.